A Randomize, Phase 2, Open-Label Study Evaluating

Konety, Badrinath R (PI)

Urology

Project: Research project

Description

A Randomized, Phase 2, Open-Label Study Evaluating DN24-02 As Adjuvant Therapy In Subjects with High Risk HER2+ Urothelial Carcinoma

Status	Finished
Effective start/end date	3/3/11 → 12/31/20

Funding

DENDREON CORPORATION